The cellular response to DNA damage is a crucial surveillance mechanism that maintains genomic integrity and prevents cancer progression. Previous studies identified multiple Ser/Thr protein kinases that have pivotal roles in the activation of this response. It is interesting that a growing body of evidence suggests that these kinases and their substrates are under tight modulation by numerous Ser/Thr phosphatases. In this study, we review recent reports that reveal new functions and regulation of these phosphatases. Similar to the kinases in this pathway, phosphatases may also be intimately involved in cancer progression and present valuable targets for cancer therapy.
Introduction
A fundamental task of the cell is to pass intact copies of its genetic information to its daughter cells. This process is constantly challenged by DNA damage, induced endogenously or exogenously. To protect genomic integrity after DNA damage, cells have evolved surveillance mechanisms, generally termed 'the DNA damage response (DDR)'. The DDR encompasses DNA repair and signal transduction pathways that activate cell-cycle checkpoints to arrest cell-cycle progression or induce apoptosis (Zhou and Elledge, 2000; Halazonetis et al., 2008) . Among all types of DNA damage, double strand breaks (DSBs) are believed to be the most dangerous. DSBs occur naturally during V(D)J recombination and meiosis, and can be induced by oxidative stress, radiation or genotoxic chemicals. DSBs present a major threat to genomic integrity by promoting chromosomal instability, a defining characteristic of most human cancers, and cells bearing unrepaired DSBs must be eliminated by the DDR before further proliferation (Khanna and Jackson, 2001 ). The importance of this pathway has been highlighted by evidence that DDR deficiencies cause severe diseases, including cancers, in humans and animal models.
The classic model of DDR activation emphasizes the central roles of a group of Ser/Thr kinases that mediate DNA damage-induced signal transduction, and are often mutated during cancer progression (Motoyama and Naka, 2004) . Protein phosphorylation catalyzed by Ser/Thr kinases can be reversed by Ser/Thr phosphatases, which have been increasingly implicated in recovery from DNA damage and other aspects of DDR regulation. In this review, we summarize recent progress in the field of DDR phosphatases, with particular attention given to the specific functions and regulation of these enzymes; we also discuss the potential critical role of these phosphatases in cancer progression and treatment.
DDR activation relies heavily on protein phosphorylation
At the heart of the molecular pathway of the DSB response is the phosphoinositide 3 kinase-related kinase Ataxia-telangiectasia mutated (ATM), which is mutated in the human disease Ataxia-telangiectasia. ATM kinase activity is increased within minutes after DNA damage, resulting in phosphorylation of numerous physiological substrates that control various pathways of DNA repair, checkpoint control, apoptosis and transcription (Shiloh, 2003;  Figure 1 ). In a well-studied example, the checkpoint kinases, Chk1 and Chk2, are phosphorylated and activated in an ATM-dependent manner, which in turn lead to Cdc25 phosphorylation and its proteolysis or nuclear export. Subsequently, reduced dephosphorylation of Cdks at inhibitory residues by Cdc25 prevents Cdk activation and cell-cycle progression. Moreover, in response to DNA damage, ATM and Chk2 phosphorylate p53, a major tumor suppressor. Phosphorylation of p53 leads to its stabilization and enhanced transcription of both p21, which inhibits CDK2 and Bax, which induces apoptosis (reviewed in (Shiloh, 2003) ). ATMdependent signal transduction is facilitated by its recruitment to chromatin areas flanking DSBs through DSB sensor/adaptor proteins, including the Mre11/ Rad50/Nbs1 complex, MDC1 and g-H2AX (Lou et al., 2006) . In addition to ATM, another phosphoinositide 3 kinase-related kinase, ATR , is also involved in DNA damage-induced signal transduction. ATR shares a similar spectrum of substrates with ATM and was, therefore, thought to have a redundant role with ATM. However, recent studies indicate that ATM and ATR are involved differently in cellular responses to various types of DNA damage. ATR is the primary kinase activated in response to replication stress, whereas its activation by DSBs is delayed and requires ATM and Mre11-dependent strand resection (Jazayeri et al., 2006; Myers and Cortez, 2006) .
Phosphorylation of substrate proteins at Ser/Thr residues by active DDR kinases, including ATM, ATR, Chk1 and Chk2, is an essential aspect of DDR signaling. In addition, phosphorylation of these kinases themselves is generally involved in their activation. A previous report suggested that ATM activation is associated with its autophosphorylation at Ser 1981 and dissociation from a dimer into a monomer (Bakkenist and Kastan, 2003) . Therefore, the level of phosphorylation at this site has been widely used as indicator of ATM activation. Moreover, ATM autophosphorylation at Ser 1981 has been shown to promote interaction with MDC1 and sustain ATM localization at DSB sites, thereby contributing to the in vivo function of ATM in the DDR (So et al., 2009) . A recent study in human cells identified two additional sites in ATM, Ser 367 and Ser 1893, that are phosphorylated after DNA damage (Kozlov et al., 2006) . It appears that phosphorylation at all three serine residues is required for ATM activation, as phospho-deficient mutants exhibit impaired kinase activation and fail to correct radiosensitivity and DNA damage checkpoint defects in ATM-deficient cell lines derived from ataxia-telangiectasia patients. (Bakkenist and Kastan, 2003; Kozlov et al., 2006) . However, the exact role of these phosphorylation events remains unclear as these phosphorylation sites are dispensable for murine ATM activation (Pellegrini et al., 2006; Daniel et al., 2008) . ATM and ATR-dependent phosphorylation has a key role in activation of Chk1 and Chk2. In response to DNA damage, ATM phosphorylates Chk2 at Thr 68 in the N-terminal SQ/TQ region, enabling its binding to the FHA domain of another Chk2 molecule and intermolecular autophosphorylation at Thr 383 and 387 in the kinase domain. Subsequently, activated Chk2 dissociates into a monomer and phosphorylates several key substrates, including Brca1, p53 and so on (reviewed in Ahn et al., 2004; Reinhardt and Yaffe, 2009 ). Recent studies have identified additional phosphorylation sites in Chk2, including Ser 19, Ser 33 and Ser 35 in the SQ/TQ region that are targeted by ATM, and Ser 516 that is autophosphorylated in cis (Mochan et al., 2003; Schwarz et al., 2003; Wu and Chen, 2003; Kurz et al., 2004; Buscemi et al., 2006) . Phosphorylation at all these sites has been shown to contribute to Chk2 activation and function (Schwarz et al., 2003; Wu and Chen, 2003; Buscemi et al., 2006) . Similarly, DNA damage-induced Chk1 phosphorylation at Ser 317 and 345 results in kinase activation and phosphorylation of downstream targets (Zhao and Piwnica-Worms, 2001; Reinhardt and Yaffe, 2009 ).
Serine/threonine phosphatases
Ser/Thr phosphatases are known regulators of a variety of cellular processes, including gene transcription, RNA splicing, DNA replication and many cell signaling pathways (Moorhead et al., 2007; Virshup and Shenolikar, 2009 ). Ser/Thr protein phosphatases (PP) have been classified biochemically into type 1 (PP1) and type 2 (PP2). In humans, PP1 contains three isoforms (a, b and g), each encoded by a distinct, but related, gene. Recent studies show that PP1 isoforms display different patterns of subcellular localization (Trinkle-Mulcahy et al., 2001) , indicating distinct functions and mechanisms of regulation. Moreover, PP1 achieves its functions through complexing of the catalytic subunit with Figure 1 DDR signal transduction relies on activated Ser/Thr kinases and protein phosphorylation (marked in red). In response to DNA DSBs, ATM is activated and, in turn, phosphorylates multiple substrates to regulate cell-cycle checkpoints, DNA repair and apoptosis. The critical involvement of other Ser/Thr kinases, including ATR, DNA-PK, Chk1 and Chk2, is also shown in the model.
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A Peng and JL Maller specific targeting subunits, which control localization and substrate specificity. Most known PP1 targeting subunits contain an RVxF motif, believed to be the primary docking site for PP1 (Moorhead et al., 2007) . PP2 is further divided into three groups on the basis of metal-dependence: metal-independent PP2A, PP4, PP5 and PP6; Ca þ þ -dependent PP2B and PP7; and Mg þ þ / Mn þ þ -dependent PP2C. Among the metal-independent group members, PP4 and PP6 share high homology with PP2A and are referred as PP2A-like phosphatases. PP2A exists in the cell as a heterodimer or heterotrimer. In a typical trimeric complex, the catalytic subunit (C) of PP2A binds to a scaffold subunit (A) on its Cterminus and a targeting subunit (B) near its active site. Humans have two isoforms of PP2A catalytic subunit (PP2ACa and PP2ACb), two scaffold subunits (PR65a and PR65b), and dozens of targeting subunits (B, B 0 , B 00 and B 000 families) that define the substrate specificity of the PP2A holoenzyme (Moorhead et al., 2007) . PP2C belongs to the Mn 2 þ /Mg 2 þ -dependent PPM family and is insensitive to inhibition by okadaic acid or microcystin. PP2C is highly conserved and encoded by seven genes in Saccharomyces cerevisiae and 16 genes in humans. Unlike PP1 and PP2A, PP2C isoforms contain specific regulatory and targeting domains on both sides of the catalytic domain. Family members of PP2C are essential regulators of various cellular processes, including stress signaling, cell differentiation, growth, apoptosis and others (Lu and Wang, 2008) . As an example, PP2Cd, also known as Wip1 (wild-type p53-induced phosphatase 1) has been shown to antagonize activation of multiple components of the stress and DDR pathways (Lu et al., 2007) .
Historically, Ser/Thr phosphatases, particularly PP1 and PP2A, were thought to act with little specificity based on two lines of evidence: first, the catalytic subunits function non-specifically to dephosphorylate many substrates in vitro; and, second, a much lower number of genes encode Ser/Thr phosphatase catalytic subunits relative to Ser/Thr kinases. However, taking into account the vast array of regulatory/targeting subunits, recent studies argue that the Ser/Thr phosphatase family exhibits similar complexity and specificity as Ser/Thr kinases (Virshup and Shenolikar, 2009) .
DDR regulation by Serine/Threonine phosphatases
Given that phosphorylation at Ser/Thr sites represents an essential element of the DDR and that it takes both protein kinases and PPs to regulate reversible phosphorylation, it is not surprising that evidence for involvement of PPs in DDR regulation is emerging. Several groups of Ser/Thr phosphatases, particularly PP2Cd/Wip1, PP2A and PP1, have been linked to DDR regulation (Heideker et al., 2007) . We recently showed that simultaneous inhibition of PP1 and PP2A efficiently turns on DDR signaling in Xenopus egg extracts even without actual DNA damage. In contrast, inhibition of either PP1 or PP2A alone was not sufficient to activate the DDR (Peng et al., 2010) . These findings underscore the essential role of both PP1 and PP2A as homeostatic regulators of the DDR. Below we summarize recent evidence revealing specific regulation of DDR factors by Ser/Thr phosphatases.
Protein phosphatase-dependent regulation of g-H2AX One of the best-studied examples comes from the dephosphorylation of g-H2AX, an isoform of histone H2A phosphorylated at a conserved C-terminal Ser residue (Ser 139 in human). The formation of g-H2AX occurs rapidly in response to DNA damage and is required for recruiting DDR factors onto damaged chromatin. Recent studies in cells and mouse models have made a convincing case that g-H2AX is critical for DNA repair and efficient activation of the DNA damage-induced checkpoint. In addition, H2AX haploinsufficiency results in increased genomic instability and cancer susceptibility in the absence of p53 Fernandez-Capetillo et al., 2002; Stucki and Jackson, 2006) . A study in yeast identified Pph3, the orthologue of mammalian PP4, as a key element of checkpoint recovery that dephosphorylates g-H2AX (Keogh et al., 2006) . Consistent with this study, a specific PP4 complex in mammalian cells, containing PP4C as the catalytic subunit, PP4R2 as the scaffold subunit and PP4R3b as the targeting subunit, is responsible for g-H2AX dephosphorylation during checkpoint recovery and DNA replication (Nazarov et al., 2003; Keogh et al., 2006; Chowdhury et al., 2008) . Moreover, Chowdhury et al. (2005) have shown that PP2A associates and colocalizes with g-H2AX, and dephosphorylates g-H2AX after DNA damage. PP6, another PP2A-like phosphatase, has also been implicated in g-H2AX dephosphorylation mediated by regulatory subunits PP6R1, PP6R2 or PP6R3 (Douglas et al., 2010) .
Recently, it has been suggested that Wip1 also participates in g-H2AX dephosphorylation after DNA damage (Cha et al., 2010; Macu˚rek et al., 2010; Moon et al., 2010) . Furthermore, Glc7, the PP1 homolog in Saccharomyces cerevisiae, dephosphorylates H2A at Ser 129 and is required for recovery from checkpoints induced by replication stress and DSBs (Bazzi et al., 2010) . It would be interesting to confirm PP1-dependent regulation of g-H2AX in higher organisms and study whether an evolutionally conserved targeting subunit is responsible for this regulation. Taken together, these studies suggest a complex mode of g-H2AX regulation by multiple phosphatases (Figure 2a ). It is interesting that, although inhibition of each individual g-H2AX phosphatase results in a sustained increase in g-H2AX level and recruitment of downstream factors to DNA damage sites, the impact on DNA repair appears different for different phosphatases. Two independent studies found that silencing PP2A expression by RNAi results in pronounced defects in DNA damage repair (Chowdhury et al., 2005; Nakada et al., 2008) . It is thus possible that the increased g-H2AX level in PP2A-deficient cells is partly due to reduced repair. However, inhibition of PP4 by siRNA or depletion of Glc1/PP1 had no significant effect on DNA repair and knockdown of Wip1 by shRNA promoted repair of DNA DSBs (Bazzi et al., 2010; Moon et al., 2010) .
Protein phosphatase-dependent regulation of ATM ATM is a master regulator of the DDR the mutation of which results in Ataxia-telangiectasia syndrome, characterized by cell-cycle checkpoint and DNA repair defects, radiosensitivity, and chromosomal instability at the cellular level and early onset neurodegeneration, immunodeficiency, sterility and lymphoid malignancy at the organismal level (Shiloh, 2003) . Khanna and colleagues showed that in undamaged cells, ATM associates with a portion of enzymatically active PP2A. The interaction is probably mediated through direct interaction between ATM and the scaffold subunit of PP2A (PP2A-A), as demonstrated by their interaction in yeast two-hybrid analysis. Inhibition of PP2A by okadaic acid was insufficient to activate ATM kinase, but increased ATM autophosphorylation at Ser 1981, and promoted ATM activation synergistically with low dose DNA damage, thus defining PP2A as a critical regulator of ATM (Goodarzi et al., 2004) . A similar role in the regulation of ATM autophosphorylation and activation has also been reported for Wip1, which, similar to PP2A, associates with ATM and regulates its activation. Wip1 expression is induced within hours after DNA damage, in correlation with reduced ATM phosphorylation at Ser1981, whereas in Wip1-deficient cells, ATM phosphorylation is both enhanced in intensity and sustained in duration (Shreeram et al., 2006a) . We recently reported essential regulation of ATM activation by PP1, an abundant phosphatase that is less studied in the DDR pathway. In Xenopus egg extracts, inhibition of PP1 was not sufficient to activate the DNA damage signaling, but promoted its activation in response to low dose DNA damage. PP1-dependent regulation of ATM is mediated by its chromatin-recruiting subunit, Repo-Man (recruits PP1 onto mitotic chromatin at anaphase, also known as Cdca2), which binds ATM and PP1g through distinct domains. In undamaged cells, Repo-Man and ATM extensively colocalize on chromatin. Inhibition of RepoMan or PP1g enhances ATM activation and autophosphorylation at Ser 1981 in both Xenopus egg extracts and human cells, and consequently the level of Repo-Man expression determines the threshold of DNA damage required for checkpoint activation (Peng et al., 2010) .
It should be noted that none of the studies summarized above examined whether other sites of ATM autophosphorylation, including Ser 367 and Ser 1893, are also targeted by the same phosphatases. Given that all these sites are required for full activation of ATM by DNA damage, their potential regulation by PPs may reveal certain mechanistic insights into ATM regulation. In particular, it would be interesting if these sites were differentially regulated by different phosphatases.
Intriguingly, although the studies discussed above present an attractive mode of phosphatase-dependent Serine/threonine phosphatases in cancer A Peng and JL Maller ATM deactivation through dephosphorylation at its activating sites (Figure 2b ), Wang and colleagues showed that PP 5 (PP5) associates with ATM and is required for its activation by DNA damage (Ali et al., 2004) . These observations in human cells were confirmed in mouse embryonic fibroblast cells derived from PP5 knock-out mice (Yong et al., 2007) . A potential explanation for this interesting finding is that PP5 dephosphorylates ATM at a yet-to-be-identified inhibitory site(s). Other possibilities, however, include action of PP5 through an ATM activator or inhibitor, and await further investigation (Figure 2b ). The same group went on to show that PP5 has a similar role for ATR as for ATM: PP5 associates with ATR and is required for ATR-dependent phosphorylation of Chk1 and Rad17 in response to UV or hydroxyurea (Zhang et al., 2005) . Taken together with another report showing that PP5 associates with and regulates DNA-PKcs (Wechsler et al., 2004) , these studies define PP5 as a general regulator of phosphoinositide 3 kinase-related kinases involved in the DDR.
Protein phosphatase-dependent regulation of Chk1
Checkpoint kinase 1 (Chk1) is activated by DNA damage-induced phosphorylation at Ser 314 and Ser 345 (Zhao and Piwnica-Worms, 2001) . A number of phosphatases have been shown to regulate phosphorylation of Chk1 at these activating sites (Figure 2c ). In S. Pombe, dephosphorylation of Chk1 by Dis2 (a PP1 homolog) allows mitotic entry upon completion of DNA repair in G2 (den Elzen and O'Connell, 2004) . To date, it is unknown whether this regulation is conserved in higher eukaryotes or which targeting subunit mediates this regulation. In human cells, Wip1 binds Chk1, resulting in its dephosphorylation at Ser 345 (Lu et al., 2005) . It is interesting that the same region in Wip1 mediates interaction with both Chk1 and Chk2. With respect to PP2A-mediated Chk1 dephosphorylation, Piwnica-Worms and colleagues (LeungPineda et al., 2006) reported a regulatory circuit in which PP2A dephosphorylates Chk1 at both Ser 317 and 345, and is negatively regulated by Chk1 kinase activity.
Protein phosphatase-dependent regulation of Chk2 Chk2, a major transducer of DNA damage signaling, relies on ATM-dependent phosphorylation for activation and in turn phosphorylates a number of downstream effectors to control checkpoint activation, DNA repair and apoptosis. Phosphorylation and activation of yeast Chk2, Rad53, is negatively regulated by Pph3 (O'Neill et al., 2007) . It is of note that, although Pph3 also dephosphorylates g-H2AX, it may involve a different mechanism for targeting: the regulatory subunit Psy 2 directly mediates Pph3 interaction with Chk2, and regulatory subunits Psy 4/Psy 2 together bring Pph3 to g-H2AX (Keogh et al., 2006) . In yeast, Ptc2 and Ptc3, two PP2C phosphatases, have been shown to dephosphorylate Rad53 so as to allow recovery from the DNA damage checkpoint (Leroy et al., 2003) . It is interesting that the involvement of these phosphatases in the regulation of Rad53 phosphorylation and checkpoint recovery seems coordinative rather than redundant. For example, the triple negative yeast strain (Ptc2, Ptc3 and Pph3-depleted) exhibits a much stronger defect in deactivating Rad53 induced by DNA damage than single negative or Ptc2/3 double negative strains (Travesa et al., 2008) . In concert with this idea, previous studies show these phosphatases bind to and regulate distinct domains of Rad53: Pph3/Psy2 recognizes the central kinase domain of Rad53, whereas the N-terminal FHA domain of Rad53 binds Ptc2 phosphorylated at Thr 376, a site targeted by the casein kinase 2 (Leroy et al., 2003; Guillemain et al., 2007; O'Neill et al., 2007) . Finally, even the Ptc2, Ptc3 and Pph3 triple-negative strain still efficiently removes Rad53 phosphorylation induced by replication stress, suggesting involvement of other phosphatase(s) under this condition (Travesa et al., 2008) . Glc7/PP1 appears to be a plausible candidate, owing to the fact that it is required for dephosphorylation of Rad53 and recovery from the replication checkpoint (Bazzi et al., 2010) . Despite this evidence, a potential direct connection between Rad53 and Glc7 remains to be verified. It is unclear whether PP4, the human homolog of Pph3, regulates Chk2, but several lines of evidence have linked PP2A, which also shares high similarity with Pph3, to Chk2 dephosphorylation (Dozier et al., 2004; Liang et al., 2006; Freeman et al., 2010) . It is interesting that these studies identified multiple targeting subunits of PP2A, including B 0 g1-3, B 0 a and so on, that interact with Chk2 and mediate its dephosphorylation by PP2A. Similar to Ptc2 and Ptc3 in yeast, human Wip1 associates with Chk2 and dephosphorylates Chk2 at Thr 68 Yoda et al., 2006; OlivaTrastoy et al., 2007) . However, distinct from the case with Ptc2 and Rad53 in yeast, interaction between Wip1 and Chk2 is mediated through the N-terminal SQ/TQ region in Chk2 and an N-terminal domain in Wip1 (Yoda et al., 2006;  Figure 2d ).
Protein phosphatase-dependent regulation of p53 p53 is a key tumor suppressor that governs cellular antiproliferative activities, particularly cell-cycle checkpoints, senescence and apoptosis. In response to stress or DNA damage, p53 is stabilized and activated through post-translational modifications, including phosphorylation within its N-terminal motif by DDR kinases, such as ATM, ATR and Chk2. Active p53 modulates transcription of an array of genes involved in cell-cycle checkpoints and apoptosis (reviewed in (Efeyan and Serrano, 2007) ). Wip1 is among those the expression of which is induced by DNA damage in a p53-dependent manner. It is interesting that Wip1 dephosphorylates p53 at Ser 15, a site targeted by ATM/ATR, resulting in increased p53 binding to the E3 ubiquitin ligase Mdm2 that mediates p53 degradation (Lu et al., 2005) . Moreover, Wip1 also reverses ATM-dependent phosphorylation of Mdm2 at Ser 395 to stabilize Mdm2 and increase Mdm2-dependent ubiquitination and proteolysis of p53 (Lu et al., 2007) . These results reveal a negative feedback mechanism in which p53 activates Wip1 to reduce its own stability through the Mdm2 pathway.
DNA damage-induced p53 phosphorylation and transcriptional activity is also controlled by PP1, which dephosphorylates p53 at Ser 15 and Ser 37 (Li et al., 2006) . PP1-dependent regulation of p53 is at least partly mediated by its nuclear targeting subunit PNUTS (Lee et al., 2007) , and other studies have found additional factors involved in this regulation. For example, p53BP2 binds to both PP1 and p53 and fine-tunes PP1 activity towards specific substrates (Helps et al., 1995) . Growth arrest and DNA damage-induced gene 34 (GADD34), a known regulator of PP1, was also shown to disrupt PP1 binding to p53, resulting in increased p53 phosphorylation at Ser 15 after DNA damage (Haneda et al., 2004) . Future efforts studying the mechanisms and dynamics of these regulatory pathways are important.
Earlier work suggested that PP2A does not regulate p53 phosphorylation at Ser 15 as PP2A inhibition by SV40 small T antigen did not enhance p53 phosphorylation at Ser 15 (Haneda et al., 2004) . Larner and colleagues recently confirmed that specific inhibition of PP2A by Calyculin A had no effect on DNA damageinduced p53 phosphorylation at Ser 15, whereas strongly increased p53 phosphorylation at Ser 46 was evident (Mi et al., 2009b) . Similarly, PP2A has been shown to associate with p53 and dephosphorylate it at Ser 37 after DNA damage, and thereby controls its transcriptional activity (Dohoney et al., 2004) . Perhaps the best characterized example of site-specific regulation of p53 by PP2A was discovered by Liu and colleagues, whose earlier work had identified a specific PP2A complex containing the B56g targeting subunit that dephosphorylates p53 at Thr 55 after DNA damage. In contrast to the effect of p53 phosphorylation at Ser 15 and other N-terminal sites, Thr 55 phosphorylation by TATA box binding protein-associated factor 1 mediates its degradation through Mdm2-dependent ubiquitination and proteolysis, so that the dephosphorylation of Thr 55 induced by DNA damage further stabilizes p53 . The authors then showed in addition that p53 phosphorylation at Ser 15 in response to DNA damage mediates recruitment of the B56g/PP2A complex, which in turn dephosphorylates Thr 55 in p53 to allow its maximal activation (Shouse et al., 2008) . These elegant studies underscore a highly coordinated and specific action of PP2A in regulating p53. It is of note that they also illustrate the ability of PP2A to regulate p53 function both negatively and positively, depending on the underlying targeting subunits (Figure 2e ).
Thanks to the enormous efforts put into revealing the emerging roles of Ser/Thr phosphatases in the DDR in the last decade, a number of PPs are now appreciated as essential regulators of an array of DDR factors. Due to space limitations, this review focuses only on phosphatase-dependent regulation of g-H2AX, ATM, Chk1, Chk2 and p53, factors critically involved in checkpoint signaling. However, other important DDR factors, particularly those in DNA repair pathways, including DNA-PK, RPA2, BRCA1 and so on, are also regulated by Ser/Thr phosphatases (Douglas et al., 2001; Liu et al., 2002; Wechsler et al., 2004; Feng et al., 2009; Mi et al, 2009a; Lee et al., 2010) . In most cases, PPs negatively regulate the DNA damage signaling, thus controlling the threshold of DDR activation and promoting DNA damage recovery, consistent with the essential role of protein kinases in activation of the response. However, PP5 positively regulates ATM/ ATR-dependent signal transduction (Ali et al., 2004; Zhang et al., 2005) , PP6 mediates DNA-PK activation (Mi et al., 2009a) , and PP2A is required for activation of the ATR/Chk1 pathway in the G2/M checkpoint response (Yan et al., 2010) . These studies suggest dephosphorylation of inhibitory sites in DDR factors is also important, and future identification of these sites will shed light on the underlying mechanisms.
Existing evidence strongly argues that the function of PP1 and PP2A in the DDR is mediated specifically by a variety of targeting subunits. However, in many cases, the underlying targeting subunits have yet to be identified and mechanistic aspects are largely unknown. Studies also indicate that Wip1 has a general role in dephosphorylating multiple phospho-S/TQ sites targeted by ATM/ATR, including those in ATM itself and its substrates. Similar to other members of the PP2C family, Wip1 contains modular domains on its N-and C-terminus that direct the interaction with specific substrates (Moorhead et al., 2007) . It is interesting that a recent study suggested that the active site in Wip1 directly docks with various pS/TQ motifs (Yamaguchi et al., 2007) . Although the existing evidence undoubtedly supports involvement of PPs in regulating DDR factors, they also raised the interesting question of why a single DDR factor is often regulated by multiple phosphatases. This complex pattern of regulation may reflect coordinate actions by the phosphatases to provide extra controllability and responsiveness of the DDR. For example, phosphatases may regulate distinct pools of ATM. Although Repo-Man/PP1 extensively colocalizes with ATM on chromatin, PP2A and Wip1 may regulate ATM in soluble fractions. Some DDR phosphatases associate with their targets before DNA damage, whereas in other cases, association is induced or enhanced by DNA damage; Wip1-dependent regulation may only function several hours after DNA damage. Thus regulation by different phosphatase complexes differs in timing. Other possibilities, such as site-specific and stress type-specific regulation by phosphatases, have also been implicated, especially for Chk2 and p53. Obviously, these ideas, though attractive, need to be further evaluated in future studies.
Regulation of the DDR phosphatases by DNA damage
With the emerging role of Ser/Thr phosphatases in DDR regulation, an important question concerns how these DDR phosphatases are themselves regulated? The responsiveness of DDR phosphatases to DNA damage has been shown in recent studies by altered localization, Serine/threonine phosphatases in cancer A Peng and JL Maller substrate association, expression, or activity after DNA damage. We reported that Repo-Man, which recruits PP1 onto chromatin to regulate ATM, is released from chromatin at DNA damage sites and dissociates from active ATM, presumably to facilitate DDR activation by DNA damage above the threshold level (Peng et al., 2010) . This implies that ATM activation involves the removal of inhibitory regulators, and future efforts to directly assess this idea are desirable. It is noteworthy that a similar mode of regulation seems applicable for the PP2A complex that binds and regulates ATM, as shown by loss of both PP2A interactions with ATM and ATM-associated PP2A activity after ionizing irradiation. DNA damage-induced dissociation of PP2A and ATM is dependent on the kinase activity of ATM, suggesting the involvement of protein phosphorylation in this process (Goodarzi et al., 2004) . In principle, reduced association of ATMregulating phosphatases at DSB sites can result in switch-like, abrupt activation of ATM by DNA damage: ATM-bound PP1 and PP2A neutralize the DNA damage signal at sub-threshold levels, whereas high dose DNA damage removes these inhibitory complexes to facilitate ATM activation. Dynamic regulation has also been reported for PP2A in controlling Chk1 phosphorylation at Ser 317 and 345. It is surprising that this function of PP2A is positively regulated by Chk1 kinase activity; in other words, Chk1 promotes its own dephosphorylation, and hypothetically, prevents its own activation in undamaged cells (Leung-Pineda et al., 2006) . It was not examined in this study how this regulation responds to full activation of DNA damage, or whether Chk1 interaction with PP2A changes following DNA damage. The mode of PP2A regulation is markedly different between Chk1 and ATM, particularly in that inhibition of ATM kinase activity resulted in persistent PP2A binding and dephosphorylation, whereas inhibition of Chk1 kinase increased the basal level of Chk1 phosphorylation (Goodarzi et al., 2004; Leung-Pineda et al., 2006) .
Compared with ATM and Chk1, Chk2 regulation by phosphatases exhibits a more complex pattern of dynamics and modulation. Chk2 was found to interact with a PP2A complex containing the B 0 a targeting subunit. It is interesting that this association is disrupted by DNA damage in a manner that depends on Chk2 phosphorylation at Ser 33 and Ser 35 by ATM (Freeman et al., 2010) . As another study has suggested involvement of other PP2A complexes targeted by B 0 g in Chk2 dephosphorylation (Dozier et al., 2004) , it would be interesting to determine whether similar dissociation between these complexes and Chk2 also occurs in response to DNA damage. This study also showed that Chk2 phosphorylates B 0 g3 in vitro, resulting in dramatically increased phosphatase activity of the B 0 g3-containing PP2A complex (Dozier et al., 2004) . However, although Chk2 also phosphorylates B 0 a in vitro, it does not seem to influence associated PP2A activity, suggesting different modes of regulation for these targeting subunits (Freeman et al., 2010) . The potential negative feedback regulation between Chk2 and B 0 g/PP2A, if further supported by in vivo evidence, may reflect PP2A function in buffering Chk2 activation or initiating Chk2 de-activation during recovery. Consistently, a recent report confirmed that pharmaceutical inhibition of Chk2 kinase activity caused elevated basal phosphorylation of Chk2, presumably through downregulation of Chk2-associated phosphatase activity (Carlessi et al., 2010) . Wip1 is another phosphatase critically involved in recovery from the DNA damage checkpoint; its expression level and association with DDR factors increase after DNA damage, and results in their dephosphorylation (Lu et al., 2007) . The N-terminal SQ/TQ region of Chk2 that interacts with Wip1 was also found to inhibit Wip1 phosphatase activity in vitro (Yoda et al., 2006) , raising an interesting possibility that mutual regulation between Wip1 and Chk2, or perhaps also between Wip1 and other substrates, takes place in the DDR, particularly in making the vital decision of whether to sustain checkpoint arrest or initiate recovery from it.
In addition to substrate association/dissociation and phosphatase activity, regulation of DDR phosphatases can be achieved by other means, including expression level and subcellular localization. The best known example comes from Wip1, the expression of which is induced by DNA damage in a p53-dependent manner (Fiscella et al., 1997) . Moreover, increased expression of PP2A catalytic subunit and the targeting subunit B56g, which regulate p53, was observed after DNA damage (Dohoney et al., 2004; Li et al., 2007) . Our recent study illustrated another interesting mode of PP1 regulation in response to DNA damage: its chromatin targeting subunit, Repo-Man, loses chromatin binding at DNA damage foci, presumably to facilitate activation of ATM-dependent signal transduction on chromatin regions surrounding DNA damage (Peng et al., 2010) . We are still in the process of investigating the underlying mechanism of DNA damage-initiated chromatin dissociation, but preliminary evidence suggests that it may be phosphorylation-dependent, as microcystin treatment also removed PP1 and Repo-Man from chromatin (Peng and Maller, unpublished data) . This model highlights the delicate regulation of DNA damage signaling events on chromatin, and is consistent with evidence that chromatin-based signal transduction promotes efficient activation of the DDR (reviewed in Wood and Chen, 2008) . It is also noteworthy that prolonged chromatin binding of DDR factors is sufficient to activate DDR signaling without actual DNA damage (Soutoglou and Misteli, 2008) . It is interesting that Wip1 has been recently shown to be chromatin-bound and further recruited to DNA damage sites. The chromatin localization pattern of Wip1 is thus in apparent agreement with its role in regulating g-H2AX (Macu˚rek et al., 2010) . In comparison, constitutive chromatin binding of PP2A is not evident. Instead, a previous study suggests that during checkpoint recovery, PP2A is recruited onto damaged chromatin to dephosphorylate g-H2AX (Chowdhury et al., 2005) .
The evidence summarized above suggests that DNA damage regulates DDR phosphatases coordinately with its regulation of DDR kinases to precisely control DDR activation and deactivation. Other studies, however, imply that DNA damage has a much broader effect on phosphatase functions in various cellular processes. It has been shown that ATM phosphorylates inhibitor-2, an inhibitory regulator of PP1, in response to DNA damage, causing its dissociation from PP1 and more than a two-fold increase in total cellular PP1 activity (Tang et al., 2008) . Another study reported an even more dramatic increase of nuclear PP1 activity after DNA damage caused by ATM-dependent dephosphorylation of PP1 (Guo et al., 2002) . The physiological effect of this striking level of increased PP1 activity post DNA damage is unclear, except that DNA damageinduced PP1 activity may inhibit Aurora-B activation and subsequently prevent histone H3 phosphorylation and the G2/M transition (Tang et al., 2008) .
Involvement of DDR phosphatases in cancer progression
The cell employs phosphatase-dependent regulatory mechanisms to control DDR activation after damage and enable deactivation during recovery. However, it has been increasingly recognized that the same pathway may be hijacked by cancer cells to evade the activation of the DDR during tumorigenesis. The oncogenic upregulation of Wip1 is by far the best-studied example of how a DDR phosphatase is intimately involved in cancer progression. Increased gene copy number and/or expression level of Wip1 has been frequently found in cancers of various types. In both human cells and mouse models, Wip1 overexpression promotes oncogene-induced cell transformation and tumorigenesis. Conversely, Wip1 inactivation enhances DNA damage checkpoint activation, confers resistance to cell transformation at the cellular level, and delays the occurrence of both oncogene-induced and spontaneous tumors (reviewed in . Of particular interest, Wip1-depletion suppresses the oncogenic potential of Myc in a mouse lymphoma model dependent on ATM and p53, but not p38/MAPK or Arf, arguing that Wip1 cooperates with Myc in lymphomagenesis through regulation of ATM and p53 in the DDR pathway (Shreeram et al., 2006b) .
We recently reported that Repo-Man expression is significantly enhanced in many cancers. Using the MCF10A breast cancer progression model, we found that upregulation of Repo-Man occurs during progression from the stage of benign lesion to the stage of malignant tumor, resulting in reduced ATM-dependent DNA damage signaling, whereas knock-down of RepoMan expression in advanced cancer cells enhanced DDR signaling and cell-cycle arrest. Moreover, RepoMan expression is required for anchorage-independent growth of the tumor cells in soft agar (Peng et al., 2010) . It remains to be further clarified whether Repo-Man has oncogenic properties in vivo, and how apparent transcriptional upregulation of Repo-Man during cancer progression is achieved. In addition to acting as potential oncogenes, DDR phosphatases may also serve as tumor suppressors through positive regulation of the DDR. For example, the tumor suppressive activity of PP2A was recently revealed to be exerted largely through B56g , the same targeting subunit involved in the DDR that dephosphorylates p53 at Thr 55 . It is thus possible that this DDR regulation of p53 partially accounts for the function of PP2A/B56g in tumor suppression. In support of this notion, a mutation in B56g that specifically disrupts its interaction with p53 and attenuates p53 activation was recently identified in lung cancer (Shouse et al., 2010) .
To conclude that phosphatase-dependent modulation of the DDR is a general mechanism for cancer progression is clearly premature, but it is nevertheless an attractive hypothesis. It has been firmly established that the DDR pathway is critical to defend genomic integrity and suppress tumor progression, whereas less understood is how tumor cells escape the DDR. Recent breakthroughs indicate that the DDR is activated to a greater extent in pre-cancerous cells than in cancerous cells (Bartkova et al., 2005; Gorgoulis et al., 2005; Halazonetis et al., 2008) . Given that the spontaneous level of DNA damage in advanced cancer cells is likely to be even higher than that in pre-cancerous cells, these lines of evidence strongly suggest that a down-shifted DDR sensitivity promotes cancer progression. This change in DDR sensitivity can not result merely from somatic mutations that cripple the DDR machinery, such as those in p53, which occur late in cancer progression and do not prevent upstream factors from being activated, or in ATM, which only accounts for a small proportion of human cancers. In light of these notions and existing studies on Wip1 and Repo-Man, it is plausible that cancer cells may initially gain resistance to the DDR through inhibitory regulation by phosphatases, thus enabling further cell proliferation with a high level of DNA damage. This process eventually facilitates acquisition of key mutations that reinforce genomic instability and further drive cancer progression (Figure 3 ).
Potential application of targeting DDR phosphatases in cancer therapy
The crucial involvement of DDR phosphatases in cancer progression may also implicate them as potential targets for cancer therapy. An interesting rationale is that if up-regulation of DDR phosphatases is essential for tumor cells to survive or proliferate with a high level of spontaneous DNA damage, then the inhibition of these phosphatases may selectively kill tumor cells or suppress their growth. In support of this idea, loss of Repo-Man and Wip1 reduced anchorage-independent growth of oncogene-transformed cells in soft agar (Bulavin et al., 2002; Li et al., 2002; Peng et al., 2010) . However, it remains to be determined whether these treatments are sufficient to exert a therapeutic effect in cancers of advanced stages, as advanced tumor cells have almost certainly acquired more genetic and epigenetic changes to disarm DDR suppression.
Chemo-or radiotherapy using DNA damaging agents remains a mainstream cancer treatment, and the therapeutic index is largely determined by the subsequent activation of the DDR in cancer and normal cells. Thus phosphatases that have essential roles in determining DDR sensitivity are attractive targets to confer enhanced chemo-or radiotherapy efficacy. In particular, in cancers in which up-regulation of certain DDR phosphatases renders tumor cells DNA damageresistant, targeting these phosphatases may selectively potentiate elimination of tumor cells in chemotherapy. In support of this idea, Wip1 targeting has been shown to benefit chemotherapy in mouse models (Belova et al., 2005; Xia et al., 2009; Hamilton et al., 2009 ). Inhibition of PP1 or PP2A has also been reported to reduce tumor resistance to radiation or chemotherapy (Lu et al., 2009; Hamilton et al., 2009) . However, because general phosphatase inhibitors affect many cellular pathways and are usually toxic, their use in cancer therapy may be limited. Instead, inhibition of specific phosphatase complexes that control the DDR likely represents an ideal therapeutic strategy. For example, in at least some cancers, targeting Repo-Man/PP1 may enhance chemotherapy as suggested by the fact that reducing Repo-Man expression can re-sensitize ATM-dependent signaling and cell-cycle arrest in advanced cancer cells and block growth in soft agar (Peng et al., 2010) .
It should be noted that most current approaches to manipulate the DDR in chemotherapy aim to exploit the vulnerability of cancer cells by targeting DNA damage checkpoint or repair factors that enable them to survive DNA damage (for example, Chk1, Chk2 and PARP; Zhou et al., 2003) . However, to re-activate or re-sensitize cellular DDRs (for example, by restoring wild-type p53) that eliminate cancer cells can be an alternative option. ATM, as a central regulator of the DDR, has been suggested to be an ideal target to enhance chemotherapy. In some cancers, ATM inhibition benefited the clinical outcome of chemotherapy (Bolderson et al., 2009) . In contrast, clinical analyses in many cancer patients show that loss of ATM frequently correlates with resistance to chemotherapy and poor patient survival (Haidar et al., 2000; Gumy-Pause et al., 2004; Austen et al., 2007) . Moreover, studies in mouse models suggest that ATM activity can both positively and negatively influence chemotherapy, depending on p53 status (Jiang et al., 2009) . It thus remains a very complex task to potentially develop enhanced chemotherapeutic strategies on the basis of our knowledge of DDR phosphatases. Nevertheless, given their known roles in the DDR and cancer, further understanding of mechanisms underlying the functions and regulation of these phosphatases may have important applications for cancer diagnosis and therapy.
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